TNFRSF6B
Basic information
Region (hg38): 20:63696652-63698684
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFRSF6B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 95 | 11 | 109 | |||
missense | 208 | 214 | ||||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 5 | 7 | |||
non coding | 24 | 31 | ||||
Total | 0 | 0 | 238 | 124 | 13 |
Variants in TNFRSF6B
This is a list of pathogenic ClinVar variants found in the TNFRSF6B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-63696774-G-T | Uncertain significance (May 18, 2022) | |||
20-63696775-C-T | Uncertain significance (Jul 30, 2023) | |||
20-63696776-G-C | Likely benign (Oct 30, 2023) | |||
20-63696780-G-A | Uncertain significance (Jul 25, 2023) | |||
20-63696783-G-A | Likely benign (Jan 05, 2024) | |||
20-63696786-C-A | Uncertain significance (Oct 08, 2023) | |||
20-63696792-C-G | Uncertain significance (Oct 04, 2022) | |||
20-63696796-C-T | Uncertain significance (Aug 04, 2023) | |||
20-63696797-G-A | Likely benign (Nov 24, 2023) | |||
20-63696797-G-T | Likely benign (Dec 01, 2022) | |||
20-63696799-T-G | not specified | Uncertain significance (Apr 18, 2023) | ||
20-63696800-G-C | Likely benign (Sep 29, 2023) | |||
20-63696801-C-G | TNFRSF6B-related disorder | Uncertain significance (Nov 08, 2023) | ||
20-63696807-C-T | Likely benign (Aug 24, 2023) | |||
20-63696809-G-A | Likely benign (Jun 13, 2022) | |||
20-63696817-C-T | Uncertain significance (Aug 02, 2023) | |||
20-63696819-C-T | Likely benign (Jan 04, 2024) | |||
20-63696822-C-T | Uncertain significance (Nov 28, 2023) | |||
20-63696823-C-T | Uncertain significance (Nov 02, 2022) | |||
20-63696827-C-G | Likely benign (Jun 03, 2023) | |||
20-63696828-C-T | Likely benign (Jan 20, 2021) | |||
20-63696829-T-C | Uncertain significance (Nov 17, 2023) | |||
20-63696831-CTGCCGG-C | Uncertain significance (Sep 30, 2023) | |||
20-63696832-T-C | TNFRSF6B-related disorder | Uncertain significance (Dec 15, 2022) | ||
20-63696835-C-T | Uncertain significance (Sep 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNFRSF6B | protein_coding | protein_coding | ENST00000369996 | 3 | 2017 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000387 | 0.219 | 123602 | 0 | 212 | 123814 | 0.000856 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.30 | 250 | 199 | 1.26 | 0.0000138 | 1845 |
Missense in Polyphen | 50 | 51.187 | 0.9768 | 540 | ||
Synonymous | -4.41 | 145 | 91.4 | 1.59 | 0.00000650 | 669 |
Loss of Function | -0.145 | 8 | 7.57 | 1.06 | 3.75e-7 | 79 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00206 | 0.00200 |
Ashkenazi Jewish | 0.000410 | 0.000403 |
East Asian | 0.00106 | 0.00104 |
Finnish | 0.00144 | 0.00140 |
European (Non-Finnish) | 0.000852 | 0.000813 |
Middle Eastern | 0.00106 | 0.00104 |
South Asian | 0.000526 | 0.000523 |
Other | 0.000694 | 0.000662 |
dbNSFP
Source:
- Function
- FUNCTION: Decoy receptor that can neutralize the cytotoxic ligands TNFS14/LIGHT, TNFSF15 and TNFSF6/FASL. Protects against apoptosis. {ECO:0000269|PubMed:21300286}.;
- Pathway
- Cytokine-cytokine receptor interaction - Homo sapiens (human);Apoptosis Modulation and Signaling;HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;DNA Double-Strand Break Repair;TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;Homology Directed Repair;Immune System;TNFs bind their physiological receptors;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Resolution of D-Loop Structures;HDR through Homologous Recombination (HRR)
(Consensus)
Recessive Scores
- pRec
- 0.169
Intolerance Scores
- loftool
- 0.370
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.88
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.258
- ghis
- 0.422
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.731
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- apoptotic process;tumor necrosis factor-mediated signaling pathway;negative regulation of apoptotic process
- Cellular component
- extracellular region;extracellular space
- Molecular function
- protein binding;signaling receptor activity